2-(4-((Ethyl(methyl)carbamoyl)oxy)phenyl)-4-oxo-4H-chromene-5,7-diyl bis(ethyl(methyl)carbamate)

ID: ALA4787451

Chembl Id: CHEMBL4787451

PubChem CID: 162667603

Max Phase: Preclinical

Molecular Formula: C27H31N3O8

Molecular Weight: 525.56

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(C)C(=O)Oc1ccc(-c2cc(=O)c3c(OC(=O)N(C)CC)cc(OC(=O)N(C)CC)cc3o2)cc1

Standard InChI:  InChI=1S/C27H31N3O8/c1-7-28(4)25(32)35-18-12-10-17(11-13-18)21-16-20(31)24-22(37-21)14-19(36-26(33)29(5)8-2)15-23(24)38-27(34)30(6)9-3/h10-16H,7-9H2,1-6H3

Standard InChI Key:  MBGXXUPMENAELF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4787451

    ---

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Cholinesterases; ACHE & BCHE (1222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
APP Tclin Amyloid-beta A4 protein (8510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ache Acetylcholinesterase (2577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bche Butyrylcholinesterase (745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ache Acetylcholinesterase and butyrylcholinesterase (AChE and BChE) (232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 525.56Molecular Weight (Monoisotopic): 525.2111AlogP: 4.81#Rotatable Bonds: 7
Polar Surface Area: 118.83Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 3.20CX LogD: 3.20
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.43Np Likeness Score: 0.12

References

1. Sang,Z.; Wang,K.; Shi,J.; Cheng,X.; Zhu,G.; Wei,R.; Ma,Q.; Yu,L.; Zhao,Y.; Tan,Z.; Liu,W..  (2020)  Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease.,  187  [PMID:31865014] [10.1016/j.ejmech.2019.111958]
2. Mi J, He Y, Yang J, Zhou Y, Zhu G, Wu A, Liu W, Sang Z..  (2022)  Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease.,  60  [PMID:35065231] [10.1016/j.bmcl.2022.128574]

Source